Esperion begins Phase IIa LUV trial

ESPR began a double-blind, placebo-controlled Phase IIa

Read the full 70 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE